Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It markets XDEMVY, an FDA-approved treatment for Demodex blepharitis, and is developing additional product candidates for ocular and infectious disease conditions.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.